Rotational Stability of Different Intraocular Lenses in The Capsular Bag

December 6, 2023 updated by: A-Yong Yu, Wenzhou Medical University
To evaluate the rotational stability difference among different intraocular lens. The rotational stability is evaluated by measurement of rotation of the IOL after surgery.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Zhejiang
      • Wenzhou, Zhejiang, China, 325000
        • Recruiting
        • Eye Hispital of Wenzhou Medical University
        • Contact:
          • AYong Yu, MD.PhD.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who received Femtosecond laser-assisted phacoemulsification surgery in The Eye Hospital of Wenzhou Medical University

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Patients who had received Femtosecond laser-assisted phacoemulsification surgery with IntelliAxis-L capsular mark.
  • The operation was smooth and there were no surgical complications.

Exclusion Criteria:

  • Corneal and other ocular diseases (such as corneal opacity, keratitis, glaucoma, uveitis, lens dislocation or subluxation, lens capsule relaxation, retinopathy, etc.);
  • History of ocular trauma or surgery before this cataract surgery;
  • intraoperative and postoperative complications, such as posterior capsule rupture, corneal endothelium decompensation;
  • Patients with severe or unstable heart, liver, kidney, lung, endocrine (including thyroid dysfunction), blood, mental dysfunction and other diseases affect the results of this study;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alignment of intraocular lens
Time Frame: 1 day postoperatively
The alignment of intraocular lens was evaluated by anterior segment photography
1 day postoperatively
Alignment of intraocular lens
Time Frame: 1 week postoperatively
The alignment of intraocular lens was evaluated by anterior segment photography
1 week postoperatively
Alignment of intraocular lens
Time Frame: 1 month, postoperatively
The alignment of intraocular lens was evaluated by anterior segment photography
1 month, postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraocular Pressure
Time Frame: 1 day, 1 week, 1 month, postoperatively
Intraocular Pressure measured by non-contact tonometers
1 day, 1 week, 1 month, postoperatively
Corrected Visual Acuity (UCVA) at Distance
Time Frame: 1 day, 1 week, 1 month, postoperatively
UCVA was determined by subjective refraction
1 day, 1 week, 1 month, postoperatively
Uncorrected Visual Acuity (UCVA) at Distance
Time Frame: 1 day, 1 week, 1 month, postoperatively
1 day, 1 week, 1 month, postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: AYong Yu, MD.PhD., Wenzhou Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 29, 2018

Primary Completion (Estimated)

June 30, 2024

Study Completion (Estimated)

October 30, 2024

Study Registration Dates

First Submitted

November 26, 2018

First Submitted That Met QC Criteria

November 29, 2018

First Posted (Actual)

December 3, 2018

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2018Rotation

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Phacoemulsification

3
Subscribe